Incyte Corporation
Clinical trials sponsored by Incyte Corporation, explained in plain language.
-
New drug targets tough cancers with KRAS G12D mutation
Disease control Recruiting nowThis early-stage study tests a new drug, INCB161734, in people with advanced solid tumors that have a specific genetic change called KRAS G12D. The main goal is to check the drug's safety and find the right dose, either alone or with other cancer treatments. About 710 adults whos…
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 29, 2026 00:51 UTC
-
New drug combo trial opens for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called INCB123667, given alone or with other cancer therapies, for adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check safety, find the right dose, and see early signs of tumor …
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 29, 2026 00:51 UTC
-
New hope for tough ovarian cancer: targeted pill vs chemo in major trial
Disease control Recruiting nowThis study tests a new oral drug, INCB123667, against standard chemotherapy for people with a specific type of ovarian cancer that has stopped responding to platinum-based treatments. The trial includes about 466 adults whose tumors have high levels of a protein called cyclin E1.…
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
New cream could soothe eczema in kids – major trial underway
Symptom relief Recruiting nowThis study tests a cream called ruxolitinib in children and teens aged 6 to 17 with moderate eczema. The goal is to see if it safely reduces skin redness, itching, and rash. About 240 participants will use either the active cream or a placebo cream for several weeks.
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Apr 29, 2026 00:52 UTC